Valuation: Southern Acids (M)

Market Cap 415M 102M 89.26M 83.09M 76.31M 143M 9.74B 145M 988M 386M 4.81B 381M 373M 16.62B P/E 2024
32.3x
P/E 2025 11.4x
Enterprise Value 48.03M 11.75M 10.33M 9.62M 8.83M 16.59M 1.13B 16.81M 114M 44.66M 557M 44.13M 43.17M 1.92B EV / Sales 2024
0.07x
EV / Sales 2025 0.05x
Free-Float
26.64%
Yield 2024
1.55%
Yield 2025 1.64%
1 day-1.30%
1 week-0.98%
Current month-3.50%
3 months-0.66%
6 months-4.72%
Current year-4.72%
1 week 3.02
Extreme 3.02
3.1
1 month 3.02
Extreme 3.02
3.12
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.6
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 47 14/07/2015
Director of Finance/CFO 58 30/09/2013
Chief Tech/Sci/R&D Officer 38 15/07/2014
Director TitleAgeSince
Director/Board Member 66 09/08/2005
Director/Board Member 59 19/03/2012
Chairman 79 14/07/2015
Change 5-day change 1-year change 3-year change Capi.($)
-1.30%-0.98%-12.43%-15.83% 103M
+2.86%-1.04%+27.73%+421.84% 5.61B
+0.14%-2.12%+25.89%+103.02% 1.72B
+6.63%+9.80%+17.69%+67.93% 796M
+0.92%-0.90%+38.74%+102.77% 554M
+4.09%-0.41%+17.33%+2.22% 536M
+3.98%-4.98%-23.69%-29.65% 469M
+0.20%+1.45%+6.47%+5.95% 374M
+2.87%+2.67%+29.58%-9.58% 356M
-0.18%-4.20%+18.67%+51.12% 286M
Average +2.02%+0.50%+14.60%+69.98% 1.08B
Weighted average by Cap. +2.50%+0.11%+23.21%+245.73%

Financials

2024 2025
Net sales 920M 225M 198M 184M 169M 318M 21.6B 322M 2.19B 856M 10.66B 845M 827M 36.86B 1.11B 271M 238M 221M 203M 382M 25.96B 387M 2.63B 1.03B 12.82B 1.02B 994M 44.3B
Net income 13.63M 3.34M 2.93M 2.73M 2.51M 4.71M 320M 4.77M 32.45M 12.68M 158M 12.52M 12.26M 546M 36.7M 8.98M 7.9M 7.35M 6.75M 12.68M 861M 12.84M 87.37M 34.12M 425M 33.72M 32.99M 1.47B
Net Debt -372M -91.09M -80.07M -74.54M -68.45M -129M -8.74B -130M -886M -346M -4.31B -342M -335M -14.91B -367M -89.78M -78.93M -73.47M -67.47M -127M -8.61B -128M -873M -341M -4.25B -337M -330M -14.69B
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,683
Date Price Change Volume
28/07/26 MYR 3.030 -1.30% 6,100
27/07/26 MYR 3.070 -0.97% 13,100
23/07/26 MYR 3.100 +1.31% 5,000
22/07/26 MYR 3.060 -1.29% 2,000
  1. Stock Market
  2. Stocks
  3. 5134 Stock